Cholesterol potentiates ABCG2 activity in a heterologous expression system: Improved in vitro model to study function of human ABCG2

Á Pál, D. Méhn, É Molnár, S. Gedey, P. Mészáros, T. Nagy, H. Glavinas, T. Janáky, O. Von Richter, G. Báthori, L. Szente, Peter Krajcsi

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

ABCG2, a transporter of the ATP-binding cassette family, is known to play a prominent role in the absorption, distribution, metabolism, and excretion of xenobiotics. Drug-transporter interactions are commonly screened by high-throughput systems using transfected insect and/or human cell lines. The determination of ABCG2-ATPase activity is one method to identify ABCG2 substrate and inhibitors. We demonstrate that the ATPase activities of the human ABCG2 transfected Sf9 cell membranes (MXR-Sf9) and ABCG2-overexpressing human cell membranes (MXR-M) differ. Variation due to disparity in the glycosylation level of the protein had no effect on the transporter. The influence of cholesterol on ABCG2-ATPase activity was investigated because the lipid compositions of insect and human cells are largely different from each other. Differences in cholesterol content, shown by cholesterol loading and depletion experiments, conferred the difference in stimulation of basal ABCG2-ATPase of the two cell membranes. Basal ABCG2-ATPase activity could be stimulated by sulfasalazine, prazosin, and topotecan, known substrates of ABCG2 in cholesterol-loaded MXR-Sf9 and MXR-M cell membranes. In contrast, ABCG2-ATPase could not be stimulated in MXR-Sf9 or in cholesterol-depleted MXR-M membranes. Moreover, cholesterol loading significantly improved the drug transport into inside-out membrane vesicles prepared from MXR-Sf9 cells. MXR-M and cholesterol-loaded MXR-Sf9 cell membranes displayed similar ABCG2-ATPase activity and vesicular transport. Our study indicates an essential role of membrane cholesterol for the function of ABCG2.

Original languageEnglish
Pages (from-to)1085-1094
Number of pages10
JournalJournal of Pharmacology and Experimental Therapeutics
Volume321
Issue number3
DOIs
Publication statusPublished - Jun 2007

Fingerprint

Adenosine Triphosphatases
Cholesterol
Sf9 Cells
Cell Membrane
Membranes
Insects
Topotecan
Sulfasalazine
In Vitro Techniques
Prazosin
Xenobiotics
Drug Interactions
Glycosylation
Human Activities
Adenosine Triphosphate
Lipids
Cell Line
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cholesterol potentiates ABCG2 activity in a heterologous expression system : Improved in vitro model to study function of human ABCG2. / Pál, Á; Méhn, D.; Molnár, É; Gedey, S.; Mészáros, P.; Nagy, T.; Glavinas, H.; Janáky, T.; Von Richter, O.; Báthori, G.; Szente, L.; Krajcsi, Peter.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 321, No. 3, 06.2007, p. 1085-1094.

Research output: Contribution to journalArticle

Pál, Á ; Méhn, D. ; Molnár, É ; Gedey, S. ; Mészáros, P. ; Nagy, T. ; Glavinas, H. ; Janáky, T. ; Von Richter, O. ; Báthori, G. ; Szente, L. ; Krajcsi, Peter. / Cholesterol potentiates ABCG2 activity in a heterologous expression system : Improved in vitro model to study function of human ABCG2. In: Journal of Pharmacology and Experimental Therapeutics. 2007 ; Vol. 321, No. 3. pp. 1085-1094.
@article{797d139335bb44cea46aaef1c7679068,
title = "Cholesterol potentiates ABCG2 activity in a heterologous expression system: Improved in vitro model to study function of human ABCG2",
abstract = "ABCG2, a transporter of the ATP-binding cassette family, is known to play a prominent role in the absorption, distribution, metabolism, and excretion of xenobiotics. Drug-transporter interactions are commonly screened by high-throughput systems using transfected insect and/or human cell lines. The determination of ABCG2-ATPase activity is one method to identify ABCG2 substrate and inhibitors. We demonstrate that the ATPase activities of the human ABCG2 transfected Sf9 cell membranes (MXR-Sf9) and ABCG2-overexpressing human cell membranes (MXR-M) differ. Variation due to disparity in the glycosylation level of the protein had no effect on the transporter. The influence of cholesterol on ABCG2-ATPase activity was investigated because the lipid compositions of insect and human cells are largely different from each other. Differences in cholesterol content, shown by cholesterol loading and depletion experiments, conferred the difference in stimulation of basal ABCG2-ATPase of the two cell membranes. Basal ABCG2-ATPase activity could be stimulated by sulfasalazine, prazosin, and topotecan, known substrates of ABCG2 in cholesterol-loaded MXR-Sf9 and MXR-M cell membranes. In contrast, ABCG2-ATPase could not be stimulated in MXR-Sf9 or in cholesterol-depleted MXR-M membranes. Moreover, cholesterol loading significantly improved the drug transport into inside-out membrane vesicles prepared from MXR-Sf9 cells. MXR-M and cholesterol-loaded MXR-Sf9 cell membranes displayed similar ABCG2-ATPase activity and vesicular transport. Our study indicates an essential role of membrane cholesterol for the function of ABCG2.",
author = "{\'A} P{\'a}l and D. M{\'e}hn and {\'E} Moln{\'a}r and S. Gedey and P. M{\'e}sz{\'a}ros and T. Nagy and H. Glavinas and T. Jan{\'a}ky and {Von Richter}, O. and G. B{\'a}thori and L. Szente and Peter Krajcsi",
year = "2007",
month = "6",
doi = "10.1124/jpet.106.119289",
language = "English",
volume = "321",
pages = "1085--1094",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Cholesterol potentiates ABCG2 activity in a heterologous expression system

T2 - Improved in vitro model to study function of human ABCG2

AU - Pál, Á

AU - Méhn, D.

AU - Molnár, É

AU - Gedey, S.

AU - Mészáros, P.

AU - Nagy, T.

AU - Glavinas, H.

AU - Janáky, T.

AU - Von Richter, O.

AU - Báthori, G.

AU - Szente, L.

AU - Krajcsi, Peter

PY - 2007/6

Y1 - 2007/6

N2 - ABCG2, a transporter of the ATP-binding cassette family, is known to play a prominent role in the absorption, distribution, metabolism, and excretion of xenobiotics. Drug-transporter interactions are commonly screened by high-throughput systems using transfected insect and/or human cell lines. The determination of ABCG2-ATPase activity is one method to identify ABCG2 substrate and inhibitors. We demonstrate that the ATPase activities of the human ABCG2 transfected Sf9 cell membranes (MXR-Sf9) and ABCG2-overexpressing human cell membranes (MXR-M) differ. Variation due to disparity in the glycosylation level of the protein had no effect on the transporter. The influence of cholesterol on ABCG2-ATPase activity was investigated because the lipid compositions of insect and human cells are largely different from each other. Differences in cholesterol content, shown by cholesterol loading and depletion experiments, conferred the difference in stimulation of basal ABCG2-ATPase of the two cell membranes. Basal ABCG2-ATPase activity could be stimulated by sulfasalazine, prazosin, and topotecan, known substrates of ABCG2 in cholesterol-loaded MXR-Sf9 and MXR-M cell membranes. In contrast, ABCG2-ATPase could not be stimulated in MXR-Sf9 or in cholesterol-depleted MXR-M membranes. Moreover, cholesterol loading significantly improved the drug transport into inside-out membrane vesicles prepared from MXR-Sf9 cells. MXR-M and cholesterol-loaded MXR-Sf9 cell membranes displayed similar ABCG2-ATPase activity and vesicular transport. Our study indicates an essential role of membrane cholesterol for the function of ABCG2.

AB - ABCG2, a transporter of the ATP-binding cassette family, is known to play a prominent role in the absorption, distribution, metabolism, and excretion of xenobiotics. Drug-transporter interactions are commonly screened by high-throughput systems using transfected insect and/or human cell lines. The determination of ABCG2-ATPase activity is one method to identify ABCG2 substrate and inhibitors. We demonstrate that the ATPase activities of the human ABCG2 transfected Sf9 cell membranes (MXR-Sf9) and ABCG2-overexpressing human cell membranes (MXR-M) differ. Variation due to disparity in the glycosylation level of the protein had no effect on the transporter. The influence of cholesterol on ABCG2-ATPase activity was investigated because the lipid compositions of insect and human cells are largely different from each other. Differences in cholesterol content, shown by cholesterol loading and depletion experiments, conferred the difference in stimulation of basal ABCG2-ATPase of the two cell membranes. Basal ABCG2-ATPase activity could be stimulated by sulfasalazine, prazosin, and topotecan, known substrates of ABCG2 in cholesterol-loaded MXR-Sf9 and MXR-M cell membranes. In contrast, ABCG2-ATPase could not be stimulated in MXR-Sf9 or in cholesterol-depleted MXR-M membranes. Moreover, cholesterol loading significantly improved the drug transport into inside-out membrane vesicles prepared from MXR-Sf9 cells. MXR-M and cholesterol-loaded MXR-Sf9 cell membranes displayed similar ABCG2-ATPase activity and vesicular transport. Our study indicates an essential role of membrane cholesterol for the function of ABCG2.

UR - http://www.scopus.com/inward/record.url?scp=34248530310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248530310&partnerID=8YFLogxK

U2 - 10.1124/jpet.106.119289

DO - 10.1124/jpet.106.119289

M3 - Article

C2 - 17347325

AN - SCOPUS:34248530310

VL - 321

SP - 1085

EP - 1094

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -